SCHEMBL30217776

SCHEMBL30217776

Cc1cnc2c(C(=O)Nc3cc(F)c4nc(C)cn4c3)ccc(N3CCN(C(=O)OC(C)(C)C)CC3)c2n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 1/20 0.45
▸ MAPT P10636 6/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ THRB P10828 1/20 0.41
▸ BACE1 P56817 4/20 0.40
▸ USP30 Q70CQ3 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ TP53 P04637 2/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ GPR35 Q9HC97 1/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ NR3C1 P04150 2/20 0.37
▸ SCD O00767 1/20 0.37
▸ SCD5 Q86SK9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25097071 1.00 PTPN11 (0.45) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL30217787 0.98 PTPN11 (0.46) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL25096320 0.98 PTPN11 (0.46) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL30312613 0.94 PTPN11 (0.44) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL25095938 0.93 MAPT (0.44) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL30217608 0.93 MAPT (0.44) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL25095913 0.91 MAPT (0.44) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL30217607 0.91 MAPT (0.44) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL31082366 0.91 PTPN11 (0.42) PTPN11MAPTMEN1TSHRKMT2A
SCHEMBL28939445 0.89 PTPN11 (0.42) PTPN11MAPTMEN1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4395891-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2024-07-10 — — EP disclosed
CN-118234724-A Compounds and methods for modulating splicing 雷密克斯医疗公司 2024-06-21 — — CN disclosed
WO-2023034811-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2023-03-09 — — WO disclosed
Send feedback